Welcome to Wopular's coverage of Acquisition, Hostile Bid.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Acquisition, Hostile Bid that have been featured on main sections
of the site.
Below are topics about Acquisition, Hostile Bid. (Click on "all"
to view all articles related to the topic, including articles NOT about
Acquisition, Hostile Bid.
GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer.